TITLE

Topical Corticosteroids in Nasal Polyposis

AUTHOR(S)
Badia, L.; Lund, V.
PUB. DATE
March 2001
SOURCE
Drugs;Mar2001, Vol. 61 Issue 5, p573
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Nasal polyps are the common end-point of a number of conditions characterised by inflammation and are rarely ‘curable’ in its true sense. After consideration of the underlying aetiology and confirmation of the diagnosis, they are normally managed by a combination of medical and surgical interventions. Of these, topical corticosteroids have proved to be the medical treatment of choice. The objectives of the medical management are to eliminate or reduce the size of polyps, re-establish nasal airway and nasal breathing, improve or restore the sense of smell, and prevent recurrence of nasal polyps. The mechanism of action of corticosteroids may be by a multifactorial effect on various aspects of the inflammatory reaction, the effect being initiated by their binding to a specific cytoplasmic glucocorticoid receptor. At a cellular level, there is a reduction in the number of antigen-presenting cells, in the number and activation of T cells, in the number of mast cells, and in the number and activation of eosinophils. When polyps are large (grade 3) topical medication is difficult to instil in a very blocked nose and surgery or short term systemic corticosteroids may be required. Topical corticosteroids are of use in the primary treatment of nasal polyps when they are of a small or medium size (grades 1 and 2) and in the maintenance of any therapeutic improvement. The efficacy of topical corticosteroids such as betamethasone sodium phosphate nose drops, beclomethasone dipropionate, fluticasone propionate and budesonide nasal sprays in reducing polyp size and rhinitis symptoms has been demonstrated in several randomised, placebo-controlled trials. Beclomethasone dipropionate, flunisolide and budesonide sprays have also been shown to delay the recurrence of polyps after surgery. Placebo-controlled studies of agents that have shown a significant clinical effect in the management of nasal polyposis are reviewed.
ACCESSION #
4386947

 

Related Articles

  • Systemic Corticosteroid Therapy: Pharmacology and Endocrinologic Considerations. Melby, James C. // Annals of Internal Medicine;Oct74, Vol. 81 Issue 4, p505 

    Examines the clinical pharmacology of systemic corticosteroid administration and concepts of systemic corticositeroid therapy. Actions of the corticosteroids; Biochemical and metabolic effects; Significance of the structural alterations of cortisol; Modalities of corticosteroid therapy.

  • Idiopathic retroperioneal fibrosis.  // British Medical Journal (Clinical Research Edition);4/25/1981, Vol. 282 Issue 6273, p1343 

    Examines the pathogenesis of idiopathic retroperitoneal fibrosis. Treatment with the use of ureterolysis; Chronic inflammation of connective tissues; Infiltration of lymphocytes and plasma cells.

  • Steroids for collegians. Deane, Lynne P.; M.O.R. // Cortlandt Forum;4/25/96, Vol. 9 Issue 4, p77 

    Comments on the use of corticosteroids to treat college students with moderate to severe infections mononucleosis that does not require hospitalization. Indications; Complications; Suggestions.

  • The effect of high-dose topical corticosteroid therapy on prevention of recurrent nasal polyps after revision endoscopic sinus surgery. Il Gyu Kang; Byung Ki Yoon; Joo Hyun Jung; Heung Eog Cha; Seon Tae Kim // American Journal of Rhinology;Sep/Oct2008, Vol. 22 Issue 5, p497 

    Background: Topical corticosteroid spray is widely used after endoscopic sinus surgery (ESS) to reduce the recurrence of polyposis. However, it has not always shown satisfactory results in clinical practice. We compared the effects of topical spray and high-dose topical steroid gauze packing on...

  • Severe adrenal suppression by steroid nasal drops. Gill, Geoffrey; Jones, Alan; Weston, Philip; Swift, Andrew; Strain, David // Journal of the Royal Society of Medicine;Jul2001, Vol. 94 Issue 7, p350 

    The article discusses the medical case of a 71-year-old woman who sustained severe adrenal suppression caused by the steroid nasal drops she used to treat her chronic sinusitis and recurrent nasal polyps. At the course of her treatment with various intranasal corticosteroids like betamethasone,...

  • Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: Risks and benefits. Poetker, David M. // American Journal of Rhinology & Allergy;Sep/Oct2015, Vol. 29 Issue 5, p339 

    Background: Oral steroids are synthetic mimics of adrenal cortex hormones and are considered a staple in the management of chronic rhinosinusitis due to their anti-inflammatory effects. Despite their common use, many providers are not familiar with the potential risks of the drugs. Methods:...

  • Double blind, placebo controlled trial of betamethasone nasal drops for nasal polyposis. Chalton, Rosemary; Mackay, Ian; Wilson, Robert; Cole, Peter // British Medical Journal (Clinical Research Edition);9/21/1985, Vol. 291 Issue 6498, p788 

    Investigates the efficacy of betamethasone drops in the treatment of nasal polyposis during administration. Prevention of recurrence using topical corticosteroids; Success in treatment of nasal polyps in patients; Account the success to administration topical corticosteroid nose drops.

  • Combined Oral and Intranasal Corticosteroid Therapy: An Advance in the Management of Nasal Polyposis? Mullol, Joaquim; Alobid, Isam // Annals of Internal Medicine;3/1/2011, Vol. 154 Issue 5, p365 

    The authors reflect on the efficiency of combined oral and intranasal corticosteroid therapy in nasal polyposis management. They note that corticosteroids exert anti-inflammatory effect by acting on particular receptors in human cells. They mention studies demonstrating that patients with nasal...

  • Once a day asthma treatment.  // Pediatrics for Parents;1999, Vol. 18 Issue 9, p7 

    Focuses on article about the corticosteroid treatment of childhood asthma, published in the October 15, 1998 issue of the `Doctor's Guide' periodical. Use of Pulmicort as a once-a-day treatment option for asthma; Mechanism of action of corticosteroids.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics